Site 02: Accelovance — Peoria, Illinois

Site 02: Accelovance is a clinical research site located in Peoria, Illinois, United States 61602.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Site 02: Accelovance has participated in 1 clinical trials.

Therapeutic areas: H7N9 Influenza.

Sponsors: Novartis Vaccines.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Site 02: Accelovance?

Site 02: Accelovance has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Site 02: Accelovance conducted?

Site 02: Accelovance has 1 clinical trials on record. Their work covers H7N9 Influenza.

Is Site 02: Accelovance accredited by Crixeo Health?

Site 02: Accelovance has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Site 02: Accelovance?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.